Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
about
Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt SignalingCetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids.Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinomaAn extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.Adipose Stem Cells Display Higher Regenerative Capacities and More Adaptable Electro-Kinetic Properties Compared to Bone Marrow-Derived Mesenchymal Stromal Cells.A single nucleotide polymorphism in the matrix metalloproteinase 2 promoter is closely associated with high risk of nasopharyngeal carcinoma in Cantonese from southern ChinaDifferential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines.Curcumin alleviates matrix metalloproteinase-3 and -9 activities during eradication of Helicobacter pylori infection in cultured cells and mice.Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin.Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival.Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.Emerging strategies for the early detection and prevention of head and neck squamous cell cancerPrognostic value of matrix metalloproteinases in oral squamous cell carcinoma.Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.Can MMP-9 be a Prognosticator Marker for Oral Squamous Cell Carcinoma?Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells.Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic ImplicationTargeting nitric oxide for cancer therapy.Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas.Immunohistochemically detected high expression of matrix metalloproteinase-2 as predictor of poor prognosis in Duke's B colon cancer.Molecular techniques and genetic alterations in head and neck cancer.Cancer biomarkers: are we ready for the prime time?An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasionNatural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma.Ganglioside GM3 inhibits matrix metalloproteinase-9 activation and disrupts its association with integrin.May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?Reduced nonprotein thiols inhibit activation and function of MMP-9: implications for chemoprevention.Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways.Expression of MMP2 and MMP9 (gelatinases A and B) in human colon cancer cells.Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis.Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene.Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.Genetic polymorphisms in MMP 2, 3 and 9 genes and the susceptibility of osteosarcoma in a Chinese Han population.Genetic polymorphisms in MMP 2, 3, 7, and 9 genes and the susceptibility and clinical outcome of cervical cancer in a Chinese Han population.Activity of the matrix metalloproteinase-9 promoter in human normal and tumor cells.Immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in radicular and residual radicular cystsConcomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract.
P2860
Q26738491-B0069EE4-4C91-4FE5-90B3-09467FD58712Q27329648-2898BCF7-9E44-4C1C-ABE8-3AED3C643134Q27824854-5D8022BD-DE48-4B99-9CF5-4572F34EA7BFQ28300689-AAA9CF07-05D5-405F-80D0-DEF6A557E586Q30432036-C7F4CF8B-8545-47FC-A67F-D5D356355C9BQ30829638-5C32CA4E-E26A-4D2C-A1F7-5F5C0F2D8554Q33579360-05DF0CC7-CF38-445E-8C70-9B01C87C87C6Q33781661-452E72C1-CB70-491B-9C6E-A528FD35DD66Q33809025-8B4EE347-2DE8-4F79-9458-8C874B9B9778Q33927058-F5737F0C-8866-4343-B3BA-39FAC6E0C12CQ34210631-2BD341B1-B9C7-4381-990E-CCBCE8F9A0DFQ34398874-4EE44BD7-9945-4384-BD83-C30C0C9A556AQ35064477-5430372F-7BA8-4174-9B02-10D7CB50C060Q35172778-6226F1AD-E723-4B05-B6BA-262B8E917A22Q35613476-6872B968-F865-4B0E-BEDA-63641A5C602EQ35621600-55A6FC19-5797-4070-A666-62475CCA9BA6Q35928211-AAF93C55-659E-4DA4-9D85-8967C55A98A7Q36110266-94D63A5A-C70F-49D5-88FA-0D925800F893Q36343684-F0EF49EE-0729-4CB1-ACC5-B02DDBEE4833Q36709690-5ABE3ECF-F4BE-4D7E-8E8C-6A7898BBD032Q36970784-945F3A6B-A5E0-4E1E-9ACF-6253107A73DDQ36971223-E8F20B30-5493-44C7-AB5D-8489D2360E76Q37233399-62BB1212-440A-46CD-8566-5A5C1789F8D5Q37307199-8D010BA1-9663-4742-9CDA-D76A688427A3Q37436249-A2F352F3-6724-46C0-A089-2D5AD7E1E8E5Q37743484-7AED8EB8-528D-4AF3-B78B-F937097B1B25Q38355136-117AD5B1-F61C-4312-97CE-0AF834F4B226Q38377310-E0ECD6DC-54A2-4FA6-99D7-FF77AC961661Q38739605-72698044-B03D-4519-BFA0-183EE198EC6EQ38739657-1C37250F-63AC-4B66-92BF-2B625E6E51CFQ39379601-E8529F66-0506-4696-9620-E142BD6A18A0Q39484806-7C99AE21-F313-4110-AF54-8C2F03B6C861Q39520225-AD6B75D5-41A6-411C-BB4F-DB44308E9245Q39903884-506A177C-A6D9-429A-A95B-81BF725FEBE9Q40097601-E080FA3C-34E1-4EEF-891C-9033A058ECA2Q40120968-562FD9BB-3B18-46DC-A6A9-F050CF1369EEQ40364658-1A63B359-2C74-4E52-84F5-BEF89437829DQ40586923-C9C68649-B20C-44F9-8242-E63F03419273Q41852551-18C8C4E0-263E-4DDD-9FFE-116BF349FC51Q43853392-7218D84F-D4D3-4469-9230-4229CB8BBEAD
P2860
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Expression of matrix metallopr ...... arcinoma of the head and neck.
@en
Expression of matrix metallopr ...... arcinoma of the head and neck.
@nl
type
label
Expression of matrix metallopr ...... arcinoma of the head and neck.
@en
Expression of matrix metallopr ...... arcinoma of the head and neck.
@nl
prefLabel
Expression of matrix metallopr ...... arcinoma of the head and neck.
@en
Expression of matrix metallopr ...... arcinoma of the head and neck.
@nl
P2093
P2860
P50
P356
P1433
P1476
Expression of matrix metallopr ...... carcinoma of the head and neck
@en
P2093
Emanuela Masini
Milena Paglierani
Oreste Gallo
P2860
P304
P356
10.1002/CNCR.10916
P407
P577
2002-11-01T00:00:00Z